Myocardial Disorder
Conditions
Interventions
Treatment group:Ultrasound-Guided Percutaneous Core Needle Myocardial Biopsy
Sponsors
Fujian Medical University Union Hospital
Eligibility
Sex/Gender
All
Age
14 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Aged 14 to 80 years, with clinical suspicion of rare cardiomyopathy. No severe bleeding disorders or infections. Monitoring for rejection after heart transplantation; 2. Clinical suspicion of myocarditis (such as infectious myocarditis, autoimmune myocarditis, eosinophilic myocarditis, giant cell myocarditis, etc.); 3. Suspected infiltrative cardiomyopathy (such as restrictive cardiomyopathy, cardiac amyloidosis, glycogen storage disease, hemochromatosis, etc); 4. Systemic diseases or cardiotoxic agents (e.g., chemotherapy drugs, toxins) that may involve the myocardium; 5. Cardiac tumors; 6. Unexplained hypertrophic cardiomyopathy or suspected arrhythmogenic right ventricular cardiomyopathy/dysplasia.
Exclusion criteria
Exclusion criteria: 1. Patients with bleeding disorders, severe thrombocytopenia, or those undergoing anticoagulation therapy; 2. Left ventricular biopsy is contraindicated in patients with acute myocardial infarction, mural thrombus formation in the left ventricle, or ventricular aneurysm formation; 3. Patients with significant cardiac enlargement and severe left ventricular dysfunction; 4. Patients with recent infections; 5. Patients who are unable to cooperate well; 6. Shunt defects are relative contraindications, and left ventricular biopsy should be avoided to prevent paradoxical systemic embolism.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Quality of cardiac tissue samples;Check for any abnormal conditions such as bleeding or swelling at the puncture site.;Arrhythmia, cardiac tamponade, infection and other complications; | — |
Countries
China
Contacts
Public ContactChen Sheng
Fujian Medical University Union Hospital
Outcome results
None listed